Dentsply Sirona adds director and forms growth committee
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
DENTSPLY SIRONA ( (XRAY) ) has shared an announcement.
On January 10, 2026, Dentsply Sirona expanded its Board of Directors from 10 to 11 members and appointed Donald (Don) Zurbay as a director and member of the Audit and Finance Committee, citing his extensive leadership experience in the dental and healthcare sectors, including his recent role as President and CEO of Patterson Companies and prior CFO role at St. Jude Medical. In tandem with this appointment, the Board formed a four-member, ad hoc Growth and Value Creation Committee, co-chaired by Chairman Gregory T. Lucier and President & CEO Daniel T. Scavilla, to oversee execution of the company’s Return-to-Growth action plan announced in November 2025, signaling a reinforced governance structure aimed at accelerating growth, sharpening capital allocation, and enhancing accountability to support long-term value creation for stakeholders.
The most recent analyst rating on (XRAY) stock is a Hold with a $12.00 price target. To see the full list of analyst forecasts on DENTSPLY SIRONA stock, see the XRAY Stock Forecast page.
Spark’s Take on XRAY Stock
According to Spark, TipRanks’ AI Analyst, XRAY is a Neutral.
DENTSPLY SIRONA’s overall stock score is primarily impacted by its financial performance, which shows significant challenges across income, balance sheet, and cash flow statements. The technical analysis indicates bearish trends, and the valuation metrics are concerning with a negative P/E ratio. The earnings call sentiment is negative, highlighting strategic and operational difficulties. Despite a high dividend yield, the overall outlook remains cautious due to these pressing issues.
To see Spark’s full report on XRAY stock, click here.
More about DENTSPLY SIRONA
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, developing, manufacturing, and marketing a broad range of dental and oral health products and other consumable medical devices under multiple global brands. With over a century of innovation, the company focuses on connected, high-quality solutions that advance patient care and improve the safety and efficacy of dental treatments, and is headquartered in Charlotte, North Carolina, with its shares listed on Nasdaq under the symbol XRAY.
Average Trading Volume: 3,710,381
Technical Sentiment Signal: Sell
Current Market Cap: $2.55B
For a thorough assessment of XRAY stock, go to TipRanks’ Stock Analysis page.
